Nicholson, S <br/><br/>
A randomized phase II trial of SRL172 (Mycobacterium vaccae) +/- low-dose interleukin-2 in the treatment of metastatic malignant melanoma.  [electronic resource] 

 -  Melanoma research  Aug 2003 
 - 389-93 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Evaluation Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0960-8931 
<br/><br/><label>Standard No.: </label>10.1097/00008390-200308000-00008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bacterial Vaccines--administration & dosage<br/>Disease-Free Survival<br/>Humans<br/>Immunotherapy--methods<br/>Interleukin-2--administration & dosage<br/>Melanoma--secondary<br/>Middle Aged<br/>Mycobacterium--immunology<br/>Skin Neoplasms--therapy<br/>Treatment Outcome